News

The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and treatments. IBM: International Business Machines . . . or “Incredible ...
International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum computing’s promise in medicine. While Moderna isn’t looking to replace ...
Per the agreement, IBM will give Moderna access to quantum computing systems and provide the company with support and expertise as it explores quantum approaches to drug development. In particular, ...
Moderna and IBM are joining forces to incorporate artificial intelligence (AI) and quantum computing into mRNA development, which was used to create Moderna’s COVID-19 vaccine. “We are … ...
The biotechnology and pharmaceutical firm Moderna Inc., best known for its COVID-19 vaccine, said today it’s working with IBM Corp. to explore ways in which quantum computing and generative artifici ...
Now, moving along to the IBM deal. IBM says its generative AI for therapeutics could help Moderna researchers learn more about how molecules behave -- and this may help them design new ones.
Vaccine maker Moderna and computing giant IBM are teaming up to explore how quantum computing and artificial intelligence can develop future mRNA medicines, both companies announced on Thursday ...
Garcia noted that Moderna is now part of the IBM Quantum Accelerator program, which provides the opportunity for Moderna scientists to explore how to apply quantum computing toward the development ...
Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...
Boehringer will harness an AI model trained at IBM as the Big Pharma becomes the latest to apply machine learning tools to its drug development.
Can This AI Deal With IBM Be a Game-Changer for Moderna? By Adria Cimino – Apr 22, 2023 at 6 ... Efficiency, speed, and precision all are very important in drug and vaccine development.